期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

痢疾疫苗的现状与发展趋势 被引量：4

下载PDF
导出
摘要 本文对细菌性痢疾疫苗的现状作了简要的论述 ,特别是对研究痢疾疫苗的思路与手段作了一些介绍 ,提出了一些看法 ,可供探讨。
作者 王秉瑞
机构地区 兰州生物制品研究所
出处 《微生物学免疫学进展》 2003年第4期54-59,共6页 Progress In Microbiology and Immunology
关键词 痢疾疫苗 侵袭性 非侵袭性 活疫苗 灭活疫苗
分类号 R392 [医药卫生—免疫学]
  • 相关文献

参考文献8

  • 1涂光理 张文平 杜琳等.口服福氏2a和宋内氏痢疾双价活疫苗安全性和保护效果双盲现场研究[J].中华流行病学杂志,1996,6:33-36.
  • 2Phalipon A and Sansinetti P. Live attenuated shigella flexlleri mutants as vaccine candidates against shigellasis and vectors for antigen delivery[J]. Biologicals 1995,23 : 125-134.
  • 3Cooperation Group of Dysentery Vaccine and Wang Bingrui. Study on the effect of oral immunization of T32-istrati stain against bacillary dysentery in field traiis[J]. Arch Roum Path Exp Microbiol.1984,43(3-4) :285-289.
  • 4Dani Cohen. Satly and immunogenicity of investigational Shigella conjugate vaccine In Israeli volunteers [ J ]. Inf Immun 1996,64 :4074-4077.
  • 5Trinka S C. Vaccination against Shigellosis with attenuated Shlgella flexneri 2a strain SC602[J]. Inf Immun. 1999,67:3437-3443.
  • 6Karen L K Safty. Immunogenicity and transmissibility in humans of CVD 1203 ,A live oral shigellafievned 2a vaccine candidate attenuated by deletions in aroA and virG[J]. Inf Immun 1996,64 :4542-4548.
  • 7Cohen D. Double - blind vaccine-controled randomized efficacy trial of an investigational shigella sonnei conjugate vaccine in adults[J]. Lancet 1997,349: 155-159.
  • 8IVI: Strategic Plan 2003-2007 [ C ].

共引文献1

同被引文献61

  • 1赵志强,江丽君.预防发展中国家儿童腹泻的全菌体疫苗的研制[J].国际生物制品学杂志,2006,29(4):153-155. 被引量：1
  • 2[1]Kotloff K L,Winickoff J P,Ivanoff B,et al.Global burden of Shigella infectious:implications for vaccine development and implementation of control strategies[J].WHO Bull,1999,77(4):651-665.
  • 3[2]Pack R,Wang Y P,Singh A,et al.Willingness to be vaccinated against shigella and other forms of dysentery..A comparison of three regions in Asia[J].Vaccine,2006,24(7):485-494.
  • 4[3]迮文远.预防接种手册[M].上海:上海科学技术文献出版社,2001:104-108.
  • 5[6]Cohen D,Ashkenazi S,Green M S,et al.Safety and immunogenicity of investigational Shigella conjugate vaccines in Israeli volunteers[J].Infect Immun,1996,64(10):4074-4077.
  • 6[7]Passweli J H,Harley E,Ashkenazi S,et al.Safety ard immunogenicity of improved Shigella O-specific polysaccharide-protein conjugate vaccines in adults in Israel[J].Infect Immun,2001,69(3):1351-1357.
  • 7[8]Taylor DN,Trofa A C,Sadoff J,et al.Synthesis,characterization,and clinical evaluation of conjugate vaccines composed of the O-specific polysaccharides of Shigella dysenteriae Type 1,Shigella flexneri Type 2a,and Shigella sonnei(Plesiomonas shigelloides) bound to bacterial toxoids[J].Infect Immun,1993,61 (9):3678-3687.
  • 8迮文远.预防接种手册[M].第2版,上海:上海科学技术文献出版社,2001.104-108.
  • 9Passwell J H,E.Harlev,S.Ashkenazi,et al.Safety and immunogenicity of improved Shigella O-specific polysaccharide-protein conjugate vaccines in adults in Israel[J].Infect Immun,2001,69(3):50.
  • 10Kotloff KL, Winickoff JP,Ivanoff B, et al. Global burden ofShigella infections : implications for vaccine development andimplementation of control strategies [J]. Bull World HealthOrgan, 1999, 77(8) :651-666.

引证文献4

二级引证文献7

微生物学免疫学进展
2003年 第4期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部